Lorena Raquel Lerner
Chief Science Officer; Chief Scientific Officer · 2 filings · Latest: Feb 24, 2026
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KROS | Lorena Raquel Lerner | Chief Science Officer | Feb 18, 2026 | Sale | $16.35 | 3,873 | $63.3K | 31,127 |